Both in Medical Labs
Sera Prognostics vs Biodesix
Over the past year SERA returned −45.9% and BDSX returned +249.0%; their daily moves had a correlation of 0.05.
SERA −45.9% BDSX +249.0%Growth of $1, one year, split-adjusted
| Metric | SERA | BDSX |
|---|---|---|
| Price | $2.03 | $22.86 |
| Market cap | $80.1M | $241.2M |
| Today | −0.98% | +4.15% |
| 1 month | +1.0% | −21.6% |
| 6 months | +2.0% | +132.3% |
| Year to date | −31.2% | +236.2% |
| 1 year | −45.7% | +243.8% |
| Revenue growth (YoY) | +76.5% | +34.2% |
| Gross margin | −66.7% | 82.1% |
| Net margin | −30463.3% | −27.1% |
| P/E (TTM) | — | — |
| Price / sales | 1,144.0× | 2.3× |
| Net cash | $46.4M | -$16.8M |
| Dividend yield | — | — |
| Volatility (60d) | 34.0% | 74.8% |
| Short % of float | 0.7% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).